Given that EMT and EndoMT are substantially involved in tumor neovascularization and that the mesenchymal molecule Vimentin is regarded as an independent prognosticator for poor survival [139], it is ideal to integrate Vimentin and/or EpCAM into the iFISH co-detection platform [11,12]. The gene discussed is EPCAM; the disease is neoplasm.